Medline Industries files for U.S. IPO, potential valuation near US$50 billion

Medline Industries, one of the world’s larger medical-supplies manufacturers, disclosed that its revenue rose 9.7% in H1-2025 and announced plans for a U.S. initial public offering, which could value the company around US$50 billion. The filing comes as the IPO market revives after years of sluggish listings, and reflects investor appetite for large-cap industrials with steady cash flows. The company is backed by private-equity and aims to leverage the public markets to fund growth, acquisitions and global expansion of medical-device and supply-chain operations.